NATURE’S SUNSHINE PRODUCTS, INC. Costs and Expenses
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Costs and Expenses of $82.53 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2012-11-06
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for the quarter ending 2012-09-30 was $82.53M, a 14.22% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for the quarter ending 2012-06-30 was $82.68M, a 1.29% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for the quarter ending 2012-03-31 was $83.69M, a 1.79% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for the quarter ending 2011-12-31 was $82.46M, a 4.50% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for fiscal 2011 was $347.65M, a 2.66% increase from fiscal 2010.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for fiscal 2010 was $338.65M, a 2.72% increase from fiscal 2009.
- NATURE’S SUNSHINE PRODUCTS, INC. costs and expenses for fiscal 2009 was $329.68M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2012-09-30 | $82.53M 10-Q · filed 2012-11-06 | $165.21M derived: sum of 2 quarters · filed 2012-11-06 | $248.90M 10-Q · filed 2012-11-06 | $331.36M derived: sum of 4 quarters · filed 2012-11-06 |
| 2012-06-30 | $82.68M 10-Q · filed 2012-08-03 | $166.37M 10-Q · filed 2012-08-03 | $248.83M derived: sum of 3 quarters · filed 2012-08-03 | $345.04M derived: sum of 4 quarters · filed 2012-11-06 |
| 2012-03-31 | $83.69M 10-Q · filed 2012-05-08 | $166.15M derived: sum of 2 quarters · filed 2012-05-08 | $262.36M derived: sum of 3 quarters · filed 2012-11-06 | $346.12M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-12-31 | $82.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-05 | $178.67M derived: sum of 2 quarters · filed 2012-11-06 | $262.43M derived: sum of 3 quarters · filed 2012-11-06 | $347.65M 10-K · filed 2012-03-05 |
| 2011-09-30 | $96.21M 10-Q · filed 2012-11-06 | $179.97M derived: sum of 2 quarters · filed 2012-11-06 | $265.19M 10-Q · filed 2012-11-06 | $351.53M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-06-30 | $83.76M 10-Q · filed 2012-08-03 | $168.98M 10-Q · filed 2012-08-03 | $255.33M derived: sum of 3 quarters · filed 2012-08-03 | $337.55M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $85.22M 10-Q · filed 2012-05-08 | $171.57M derived: sum of 2 quarters · filed 2012-05-08 | $253.79M derived: sum of 3 quarters · filed 2012-05-08 | $337.66M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | $86.34M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-05 | $168.56M derived: sum of 2 quarters · filed 2012-03-05 | $252.44M derived: sum of 3 quarters · filed 2012-03-05 | $338.65M 10-K · filed 2012-03-05 |
| 2010-09-30 | $82.22M 10-Q · filed 2011-11-08 | $166.09M derived: sum of 2 quarters · filed 2011-11-08 | $252.31M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $83.87M 10-Q · filed 2011-08-05 | $170.09M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $329.68M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |